Michael Truett Tate, Chief Financial Officer at Astera Labs, Inc. (ALAB), sold 661,515 shares at $109.58 ($71.6M) on 2024-12-03, disclosed to the SEC on 2024-12-04.
Scheduled sale ($71.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.62 | 24,077 | $2.4M | 3.4% |
| 2 | $101.62 | 24,077 | $2.4M | 3.4% |
| 3 | $102.59 | 55,003 | $5.6M | 7.9% |
| 4 | $102.59 | 55,003 | $5.6M | 7.9% |
| 5 | $103.49 | 84,220 | $8.7M | 12.2% |
| 6 | $103.49 | 84,220 |
| $8.7M |
| 12.2% |
| 7 | $104.44 | 3,700 | $386K | 0.5% |
| 8 | $105.80 | 1,185 | $125K | 0.2% |
| 9 | $107.08 | 1,600 | $171K | 0.2% |
| 10 | $108.16 | 1,180 | $128K | 0.2% |
| 11 | $108.16 | 1,180 | $128K | 0.2% |
| 12 | $109.58 | 4,575 | $501K | 0.7% |
| 13 | $109.58 | 4,575 | $501K | 0.7% |
| 14 | $110.52 | 21,670 | $2.4M | 3.3% |
| 15 | $110.52 | 21,670 | $2.4M | 3.3% |
| 16 | $111.32 | 19,793 | $2.2M | 3.1% |
| 17 | $111.32 | 19,793 | $2.2M | 3.1% |
| 18 | $112.53 | 27,905 | $3.1M | 4.4% |
| 19 | $112.53 | 27,905 | $3.1M | 4.4% |
| 20 | $113.54 | 18,489 | $2.1M | 2.9% |
| 21 | $113.54 | 18,489 | $2.1M | 2.9% |
| 22 | $114.54 | 19,804 | $2.3M | 3.2% |
| 23 | $114.54 | 19,804 | $2.3M | 3.2% |
| 24 | $115.71 | 25,978 | $3.0M | 4.2% |
| 25 | $115.71 | 25,978 | $3.0M | 4.2% |
| 26 | $116.46 | 23,222 | $2.7M | 3.8% |
| 27 | $116.46 | 23,222 | $2.7M | 3.8% |
| 28 | $117.10 | 1,599 | $187K | 0.3% |
| 29 | $117.10 | 1,599 | $187K | 0.3% |
| Total | $108.17 avg | 661,515 | $71.6M | 100% |
| Filing → |
| ALAB | SELL | 2025-08-20 | $6.9M | — | Filing → |
| ALAB | SELL | 2025-08-20 | $33.0M | — | Filing → |
| ALAB | SELL | 2025-08-14 | $38.2M | — | Filing → |